T cells from programmed death-1 deficient mice respond poorly to mycobacterium tuberculosis infection

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Tousif, Sultan ^a   Singh, Yogesh ^a,b   Prasad, Durbaka Vijaya Raghava ^c   Sharma, Pawan ^a   van Kaer, Luc ^d   Das, Gobardhan ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c YOGI VEMANA UNIVERSITY   (India)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MYCOBACTERIUM ANTIGEN; PROGRAMMED DEATH 1 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BACTERIAL CLEARANCE; BACTERIAL LOAD; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MESENCHYMAL STEM CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; WILD TYPE; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL PROLIFERATION; FLOW CYTOMETRY; IMMUNOLOGY; MICROBIOLOGY; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALIA; MUS; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL PROLIFERATION; FLOW CYTOMETRY; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 79955935605     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019864     Document Type: Article

References (47)

1. Barnes PF, Cave MD, (2003) Molecular epidemiology of tuberculosis. N Engl J Med 349: 1149-1156.
2. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC, (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282: 677-686.
3. Chamie G, Luetkemeyer A, Charlebois E, Havlir DV, (2010) Tuberculosis as part of the natural history of HIV infection in developing countries. Clin Infect Dis 50 (Suppl 3): S245-254.
4. Nunn P, Williams B, Floyd K, Dye C, Elzinga G, et al. (2005) Tuberculosis control in the era of HIV. Nat Rev Immunol 5: 819-826.
5. Desvignes L, Ernst JD, (2009) Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31: 974-985.
6. Kaufmann SH, Hengartner MO, (2001) Programmed cell death: alive and well in the new millennium. Trends Cell Biol 11: 526-534.
7. Baldridge MT, King KY, Boles NC, Weksberg DC, Goodell MA, (2010) Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 465: 793-797.
8. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993) Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178: 2243-2247.
9. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-2254.
10. Flynn JL, Chan J, (2001) Immunology of tuberculosis. Annu Rev Immunol 19: 93-129.
11. Harris J, De Haro SA, Master SS, Keane J, Roberts EA, et al. (2007) T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 27: 505-517.
12. Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, et al. (2007) Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 204: 2159-2169.
13. Shafiani S, Tucker-Heard G, Kariyone A, Takatsu K, Urdahl KB, (2010) Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 207: 1409-1420.
14. Raghuvanshi S, Sharma P, Singh S, Van Kaer L, Das G, (2010) Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. Proc Natl Acad Sci U S A 107: 21653-21658.
15. Okamoto Yoshida Y, Umemura M, Yahagi A, O'Brien RL, Ikuta K, et al. (2010) Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol 184: 4414-4422.
16. Keir ME, Butte MJ, Freeman GJ, Sharpe AH, (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26: 677-704.
17. Keir ME, Francisco LM, Sharpe AH, (2007) PD-1 and its ligands in T-cell immunity. Curr Opin Immunol 19: 309-314.
18. Keir ME, Latchman YE, Freeman GJ, Sharpe AH, (2005) Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes. J Immunol 175: 7372-7379.
19. Keir ME, Sharpe AH, (2005) The B7/CD28 costimulatory family in autoimmunity. Immunol Rev 204: 128-143.
20. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, et al. (2001) PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2: 261-268.
21. Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, et al. (2004) PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci U S A 101: 10691-10696.
22. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
23. Brown KE, Freeman GJ, Wherry EJ, Sharpe AH, (2010) Role of PD-1 in regulating acute infections. Curr Opin Immunol.
24. Finnefrock AC, Tang A, Li F, Freed DC, Feng M, et al. (2009) PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination. J Immunol 182: 980-987.
25. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, et al. (2006) Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 12: 1198-1202.
26. Velu V, Titanji K, Zhu B, Husain S, Pladevega A, et al. (2009) Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458: 206-210.
27. Zhang JY, Zhang Z, Jin B, Zhang SY, Zhou CB, et al. (2008) Cutting edge: programmed death-1 up-regulation is involved in the attrition of cytomegalovirus-specific CD8+ T cells in acute self-limited hepatitis B virus infection. J Immunol 181: 3741-3744.
28. Gotsman I, Grabie N, Dacosta R, Sukhova G, Sharpe A, et al. (2007) Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. J Clin Invest 117: 2974-2982.
29. Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, et al. (2001) B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 193: 839-846.
30. Liang SC, Greenwald RJ, Latchman YE, Rosas L, Satoskar A, et al. (2006) PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis. Eur J Immunol 36: 58-64.
31. Jurado JO, Alvarez IB, Pasquinelli V, Martinez GJ, Quiroga MF, et al. (2008) Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 181: 116-125.
32. Deretic V, Delgado M, Vergne I, Master S, De Haro S, et al. (2009) Autophagy in immunity against mycobacterium tuberculosis: a model system to dissect immunological roles of autophagy. Curr Top Microbiol Immunol 335: 169-188.
33. Armstrong JA, Hart PD, (1971) Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med 134: 713-740.
34. Deretic V, Singh S, Master S, Harris J, Roberts E, et al. (2006) Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell Microbiol 8: 719-727.
35. Levine B, Kroemer G, (2008) Autophagy in the pathogenesis of disease. Cell 132: 27-42.
36. Mizushima N, Klionsky DJ, (2007) Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr 27: 19-40.
37. Deretic V, (2006) Autophagy as an immune defense mechanism. Curr Opin Immunol 18: 375-382.
38. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, et al. (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119: 753-766.
39. Saunders PA, Hendrycks VR, Lidinsky WA, Woods ML, (2005) PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion. Eur J Immunol 35: 3561-3569.
40. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ, (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8: 239-245.
41. Zhong X, Bai C, Gao W, Strom TB, Rothstein TL, (2004) Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger. Int Immunol 16: 1181-1188.
42. Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A, (2011) CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J Immunol 186: 1598-1607.
43. Lazar-Molnar E, Chen B, Sweeney KA, Wang EJ, Liu W, et al. (2010) Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc Natl Acad Sci U S A 107: 13402-13407.
44. Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ, (2007) Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27: 111-122.
45. Kokkinopoulos D, Perez S, Sotiriadou R, Stinios J, Papamichail M, (1992) The use of nylon wool for the isolation of T lymphocyte subpopulations. J Immunol Methods 154: 1-6.
46. Mehta R, Pearson JT, Mahajan S, Nath A, Hickey MJ, et al. (2004) Adenylylation and catalytic properties of Mycobacterium tuberculosis glutamine synthetase expressed in Escherichia coli versus mycobacteria. J Biol Chem 279: 22477-22482.
47. Haak S, Croxford AL, Kreymborg K, Heppner FL, Pouly S, et al. (2009) IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest 119: 61-69.